About Euprotec
Euprotec is a Healthcare company based in Manchester (United Kingdom) founded in 2008, and was acquired by Evotec in May 2014. It operates as a preclinical services for anti-infective drugs are provided. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include Gentronix, BioQual, Shanghai Yaocheng Health Technology, Tigermed and ReveraGen and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Euprotec was founded in 2008 and is based in Manchester, United Kingdom. Preclinical development services for anti-infectives are offered within the biotechnology sector. A biology platform supports the creation of anti-infective drugs, vaccines, and immunotherapies. Focus areas encompass infectious diseases, respiratory conditions, and allergies. Key services include ADME and PKPD studies, efficacy testing in disease models, and a StrainBank with susceptible and resistant microbial strains representing diverse resistance profiles.
- Headquarters Manchester, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website euprotec.com
- Social LinkedIn
- Acquired by Evotec (May 2014)
Investors in Euprotec
Euprotec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Evotec.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery and development services are provided to biopharma sector. | 1993 | evotec.com | Hamburg, Germany |
Investor details for Euprotec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Euprotec
2 dated milestones of Euprotec across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Euprotec is founded.
- Exit Acquired by Evotec.
Competitors of Euprotec
Euprotec has 9 listed competitors in our database, 3 of them funded. They include Gentronix, BioQual, Shanghai Yaocheng Health Technology, Tigermed and ReveraGen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gentronix.co.uk | 1999 | Alderley Edge, United Kingdom | – | 1 | In-vitro and in-vivo genetic toxicology screening services are provided. | |
| bioqual.com | 1981 | Rockville, United States | – | 193 | Contract research on infectious disease models is conducted. | |
| yaocheng.cn | 2020 | Shanghai, China | $15.44M | – | Clinical trial services to biopharma sector are provided. | |
| tigermedgrp.com | 2004 | Hangzhou, China | – | 15 | Drug development and preclinical services are provided by Tigermed. | |
| reveragen.com | 2008 | Rockville, United States | – | – | Steroids for Duchenne muscular dystrophy treatment are developed. | |
| simrbio.com | 2014 | Shanghai, China | $20.76M | – | Diversified preclinical services for brain-related disorders are provided. | |
| phaxiam.com | 2004 | Lyon, France | $15.8M | – | Antibacterial treatments using bacteriophages are developed for resistant infections. | |
| gubra.dk | 2008 | Horsholm, Denmark | – | – | Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided. | |
| headlandsresearch.com | 2018 | San Francisco, United States | – | – | Clinical research services are provided by Headlands Research globally. |
Detailed competitors of Euprotec
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as Euprotec (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Euprotec
Euprotec was founded in 2008.
Euprotec is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Euprotec was founded in 2008 and is based in Manchester, United Kingdom. Preclinical development services for anti-infectives are offered within the biotechnology sector. A biology platform supports the creation of anti-infective drugs, vaccines, and immunotherapies. Focus areas encompass infectious diseases, respiratory conditions, and allergies. Key services include ADME and PKPD studies, efficacy testing in disease models, and a StrainBank with susceptible and resistant microbial strains representing diverse resistance profiles.
Euprotec has 1 investor. Key investors include Evotec.
Yes. Euprotec was acquired by Evotec in May 2014.